RAB42 overexpression also correlates with enhanced RNA modifications, poor tumor immune cell infiltration, and declined expression of immune checkpoint genes in cancers that are non-response to immune checkpoint inhibitors (ICIs). Here, RAB42 is linked to neoplasm.